Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Papillomavirus Infections 7Uterine Cervical Neoplasms 5Neuroendocrine Tumors 4Neoplasms 4Autoimmune Diseases 3Ovarian Neoplasms 2Myasthenia Gravis 2Mesothelioma, Malignant 2Lung Neoplasms 2Venous Thrombosis 1Venous Thromboembolism 1Uterine Cervical Dysplasia 1Thyroid Diseases 1Thrombosis 1Squamous Intraepithelial Lesions 1Retinal Telangiectasis 1Renal Insufficiency 1Recurrence 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Hairy Cell 1Hemorrhage 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1

Interventions

apixaban 11Dalteparin 10Rivaroxaban 7Enoxaparin 5Fondaparinux 4Tinzaparin 3Heparin, Low-Molecular-Weight 3Aspirin 3edoxaban 2Warfarin 2Observation 2Dabigatran 2sotorasib 1calcium heparin 1betrixaban 1bemiparin 1argatroban 1Tacrolimus 1Tablets 1Simvastatin 1Rosuvastatin Calcium 1Nadroparin 1Heparin 1Gemcitabine 1Drug Therapy 1Data Collection 1Cyclosporine 1AVE 5026 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Venous Thromboembolism × Data Collection × Clear all
NCT04846556 2023-10-11

Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO

Centre Hospitalier Universitaire de Saint Etienne

Completed
300 enrolled
Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡